Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy
Ji Won Han(The Catholic University of Korea Seoul St. Mary's Hospital), Seung Kew Yoon(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 42
Related Papers
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
|Journal of Hepatology|2016|385
EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
|Journal for ImmunoTherapy of Cancer|2020|116
Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis
|PLoS ONE|2013|47
Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133
|Scientific Reports|2017|39
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma
|International Journal of Molecular Sciences|2021|38